Prediagnostic plasma branched-chain amino acids and the risk of amyotrophic lateral sclerosis

Loading...
Thumbnail Image
Files
e2081.full.pdf(177.04 KB)
Published Version
Date
2018-11-14
Authors
Bjornevik, Kjetil
O'Reilly, Éilis J.
Berry, James D.
Clish, Clary B.
Jeanfavre, Sarah
Kato, Ikuko
Kolonel, Laurence N.
Le Marchand, Loic
McCullough, Marjorie L.
Paganoni, Sabrina
Journal Title
Journal ISSN
Volume Title
Publisher
American Academy of Neurology
Research Projects
Organizational Units
Journal Issue
Abstract
Objective: To assess whether prediagnostic levels of plasma branched-chain amino acids (BCAAs) are associated with amyotrophic lateral sclerosis (ALS) risk. Methods: We included participants from 5 large cohort studies—The Nurses' Health Study, the Health Professionals Follow-up Study, the Cancer Prevention Study II Nutrition, the Multiethnic Cohort Study, and the Women's Health Initiative—and identified 275 individuals who developed ALS during follow-up. Two controls were randomly selected for each case, matched on cohort, age, sex, fasting status, and time of blood draw. We measured metabolites using liquid chromatography–mass spectrometry and used conditional logistic regression to estimate rate ratios (RRs) and 95% confidence intervals (CIs) for the association of individual BCAAs with ALS risk. Results: None of the 3 BCAAs was associated with a higher ALS risk. The risk estimates were similar for leucine (RR top vs bottom quartile: 0.87, 95% CI 0.57–1.33), isoleucine (RR top vs bottom quartile: 0.81, 95% CI 0.52–1.24), and valine (RR top vs bottom quartile: 0.80, 95% CI 0.52–1.23) in a multivariable analysis adjusted for body mass index, smoking, level of education, and physical activity. The estimates did not vary significantly by sex, fasting status, or time interval between blood draw and disease onset. Conclusion: The results from this study do not support the hypothesis that BCAAs are risk factors for ALS.
Description
Keywords
ALS , Plasma , Branched-chain amino acids , BCAAs , Amyotrophic lateral sclerosis
Citation
Bjornevik, K., O'Reilly, É. J., Berry, J. D., Clish, C. B., Jeanfavre, S., Kato, I., Kolonel, L. N., Le Marchand, L., McCullough, M. L., Paganoni, S., Schwarzschild, M. A., Talbott, E. O., Wallace, R. B., Zhang, Z., Manson, J. E. and Ascherio, A. (2019) 'Prediagnostic plasma branched-chain amino acids and the risk of amyotrophic lateral sclerosis', Neurology, 92(18), pp. 2081-2088. doi: 10.1212/WNL.0000000000006669
Copyright
© 2018, American Academy of Neurology. All rights reserved.